NEW YORK – Which articles gained the most attention from GenomeWeb's readers last week? Here are the top five:
- Thermo Fisher Scientific Further Lowers 2023 Guidance, Provides 2024 Financial Outlook
- Polygenic Risk Scores' Predictive Power Pales in Comparison to Simpler Metrics
- Payors, Labs Parsing State Biomarker Testing Laws to Better Understand Coverage Mandates
- Precede Biosciences Debuts Chromatin-Based Liquid Biopsy Platform Backed by New Data at ESMO
- In New TRACERx Data, Personalis MRD Test Shows Improved Sensitivity With Potential Clinical Impact